PDE5A and pulmonary arterial hypertension: A series of curcumin analogues dilate rat pulmonary arteries via inhibiting phosphodiesterase-5 (PDE5) activities, suggesting that selective inhibition of PDE5 by curcumin may be a promising strategy for the prevention and treatment of PAH (Kruangtip et al., 2015).